Abstract:Purpose/Objective(s)The incidence of human papillomavirus-positive (HPV+) oropharyngeal cancer (OPC) has increased rapidly in North America. HPV serology has been proposed as a sensitive, scalable, and cost-effective early detection test. HPV seropositivity can precede clinical presentation of OPC by several years, so additional diagnostic and/or surveillance procedures may be necessary to optimize early cancer detection. The potential for HPV circulating tumor DNA (ctDNA) to confirm a diagnosis of OPC in seropositive individuals is poorly understood. Moreover, the concordance of baseline HPV serology and HPV ctDNA and their respective associations with cancer burden in OPC patients are not known. We hypothesized that plasma levels of HPV antibodies and HPV ctDNA are associated with disease burden in a cohort of p16+ OPC patients.Materials/MethodsWe analyzed pre-treatment peripheral blood plasma from 100 patients with non-metastatic p16+ OPC treated with definitive (chemo)radiotherapy. A multiplex ELISA was used for serologic evidence of HPV proteins (L1, E1, E2, E4, E6, E6) from 10 HPV genotypes, quantified by mean fluorescence intensity (MFI). Plasma HPV ctDNA was quantified by whole viral genome sequencing utilizing a custom HPV-targeted capture panel for 38 HPV genotypes (HPV-seq). Gross tumor volume (GTV) was obtained from the sum of all target contours on computed tomography simulation scans. Statistical tests Kruskal-Wallis and Pearson's r were used to compare the assays.ResultsSeropositivity and HPV ctDNA positivity were found in 100% of cases. Serological results indicated 10 genotypes, and HPV ctDNA results indicated 9 distinct genotypes; both assays identified HPV16 as the most prevalent genotype (98% for each). Among the 98 patients with detectable HPV16 within ctDNA, HPV16 E6 seropositivity demonstrated high sensitivity (95%), while E1 (50%), E4 (47%), E7 (66%), and L1 (63%) demonstrated considerably lower sensitivities. HPV ctDNA but not HPV16 E6 MFI was positively associated with disease burden as determined by T- and N-category (Table 1), and by GTV (ctDNA vs GTV, r=0.47 p=1.0e-06; E6 MFI vs GTV, r=-0.14 p=0.17).ConclusionThis is the first report to compare HPV serology and HPV ctDNA sequencing in OPC patient plasma. Both tests were highly sensitive and could identify multiple oncogenic HPV genotypes. The level of HPV16 ctDNA but not HPV16 E6 antibodies in plasma was associated with disease burden. These findings have potential implications for early detection and prognostication.

Telomere Length in Peripheral Blood Lymphocytes Contributes to the Development of HPV-Associated Oropharyngeal Carcinoma

Combined Effects of Leukocyte Telomere Length, P53 Polymorphism and Human Papillomavirus Infection on Esophageal Squamous Cell Carcinoma in a Han Chinese Population.

Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinoma.

Telomere Length in Cervical Exfoliated Cells, Interaction with HPV Genotype, and Cervical Cancer Occurrence among High‐risk HPV‐positive Women

GWAS-identified telomere length associated genetic variants predict risk of recurrence of HPV-positive oropharyngeal cancer after definitive radiotherapy

High-risk human papillomavirus infection associated with telomere elongation in patients with esophageal squamous cell carcinoma with poor prognosis.

Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population

Telomere dysfunction: a potential cancer predisposition factor.

HPV Infection and Anemia Status Stratify the Survival of Early T2 Laryngeal Squamous Cell Carcinoma.

A Systematic Investigation of the Association Between Hpv and the Clinicopathological Parameters and Prognosis of Oral and Oropharyngeal Squamous Cell Carcinomas

HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Risk-Stratification in P16+ Oropharyngeal Cancer

The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer

Understanding the impact of high-risk human papillomavirus on oropharyngeal squamous cell carcinomas in Taiwan: A retrospective cohort study

Telomere Length in White Blood Cell Dna and Lung Cancer: A Pooled Analysis of Three Prospective Cohorts

Genetic variations associated with telomere length predict the risk of recurrence of non‐oropharyngeal head and neck squamous cell carcinoma

Analysis of clinicopathological features of human papilloma virus-associated oropharyngeal squamous cell carcinoma

Constitutive Short Chromosome-Specific Telomere Length of 17p and 12q, but Not XpYp, 11q and 2p is Associated with Increased Esophageal Cancer Risk

[Human Papillomavirus Infection in Oropharyngeal Squamous Cell Carcinoma and Prognosis: a Preliminary Analysis of 66 Cases].

HPV16 infection and p16 protein expression in oropharyngeal squamous cell carcinoma and their clinical significance

Correlation of immune makers with HPV 16 infections and the prognosis in oropharyngeal squamous cell carcinoma

Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium